Nevro Stock Analysis, Valuation (NYSE:NVRO)

Add to My Stocks
$91.55 $0.64 (0.69%) NVRO stock closing price Apr 19, 2018 (Closing)
Watch Robo Advisor Video of NVRO Stock Analysis
Nevro
Updated on : Apr 18, 2018
previous close
NVRO 92.2 (0%)
S&P 500 2708.6 (0%)
Closing Price On: Apr 18, 2018
stock rating
RATING: ★★★★★★★★★★ (0/5)
Industry :
Medical Instruments
Sector :
Medical
5 Quarter Revenue
Revenue Growth
2017-Q4
$million
%
YOY GROWTH
Compared to the industry
Operating Profit
Operating Margin:
-9.1%
Sector Average:
-7.3%
5 Quarter Net Profit
Net Margins
2017-Q4
%
LTM Margin
Debt/Equity Ratio
Debt:
145M
Debt/Equity Ratio:
 0.58
Compared to the industry
Cash Flow
Operating cash flow:
-$2.4M
Net Income:
-$4.3M
PROS      CONS
Recent Growth
Operating Margins
Net Margins
High Debt Burden
ROIC
ROE
FCF Margin
Rating: ★★★★★★★★★★ (0/5)
Relative Valuation
PE: N/A
NVRO PS :
8.4
Industry PS :
5.9
Sector:   Medical.   *PE adjusted for one time items.
Other Metrics
Return on Invested Capital:
-16.1%
Return on Equity:
-15%
Free Cash Flow Margin:
-4.4%
Double Tap To Exit Full Screen
0:00
/

Nevro Stock Analysis

150 5 2

Take a look at Amigobulls Nevro stock analysis video. Our NVRO analysis video highlights revenue and profit trends along with other important metrics such as valuation to find what makes the stock attractive.

Note: Amigobulls stock rating is our opinion based on the historical performance of the company's fundamentals. It is not indicative of the future performance of the stock.

Nevro Corp Stock Rating 2.5/5

Amigobulls NVRO stock analysis uses latest quarter 2017 Q4 financial data like Nevro revenue growth, profit margins and cash flows. We compare Nevro valuation with its sector peers to gauge relative attractiveness of NVRO stock. Nevro stock rating encapsulates our opinion about the company based on the fundamentals.

Should you buy NVRO stock?

  • Nevro's revenue growth came in at 38.9% in 2017 Q4.

Should you sell NVRO stock?

  • Nevro registered a negative operating margin of -9.1% (average) over the Trailing Twelve Months (TTM).
  • Nevro posted an average Net loss of -11.2% in the last twelve months.
  • Nevro is debt laden and has a high debt/equity ratio of  0.58.
  • PE ratio is meaningless for NVRO stock as the company has losses.
  • Nevro's negative ROIC of -16.1% indicates operational inefficiency.
  • A negative ROE of -15% indicates that the company is not able to generate profits with the money shareholders have invested.
  • The company has negative Free Cash Flows (FCF), with a negative FCF margin of -4.4%.

Comments on this video and Nevro stock

Investors can make use of the Amigobulls Nevro stock analysis to ascertain how NVRO stock fares in fundamental analysis investment criteria. The fundamentals of a company are vital to identify long-term investment opportunities.

Among the financials of the company, Nevro revenue growth along with the profit or net income give a clear picture of the financial health. One can also combine technical analysis and fundamental analysis to get a holistic picture about NVRO stock.